NCI-CPTC | GenomeWeb

NCI-CPTC

In particular, George Mason University researcher Emanuel Petricoin expressed concerns about the project's plan to use samples from different patient cohorts for its discovery and verification stages.

The project is part of the CPTC's Antibody Characterization Program, which aims to thoroughly characterize all monoclonal antibodies used in the initiative in an effort to minimize the experimental variability that has often hampered the use of affinity reagents in proteomics research.

The alliance aims to take proteomics into the clinical chemistry lab and to encourage proteomics researchers to adopt procedures and processes that are routinely practiced in clinical chemistry labs.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.